Tekmira (TKMR): Analyst Warns About Premature Excitement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Tekmira Pharmaceuticals (TKMR) Adds to Gains on Overnight Ebola Developments
September 23, 2014 8:02 AM EDTEbola stock Tekmira Pharmaceuticals (NASDAQ: TKMR) continues to see out-sized gains in pre-open trading Tuesday on a host of developments overnight. After gaining 17% yesterday shares are indicated to open another 7.6% higher today. Below is a run-down of recent... More
Sacra Confirmed Treated with Tekmira's (TKMR) TKM-Ebola
September 22, 2014 6:01 PM EDTDoctors of Ebola patient Dr. Rick Sacra confirmed he was treated with Tekmira Pharmaceuticals (NASDAQ: TKMR) TKM-Ebola
Maxim Group Calls Tekmira Pharma (TKMR) News 'Ground Breaking'
September 22, 2014 1:13 PM EDTMaxim Group analyst Jason Kolbert weighed in on Tekmira Pharma (NASDAQ: TKMR) after the company announced that the FDA has authorized the use... More
Tekmira Pharmaceuticals (TKMR) Allowed by FDA to Provide TKM-Ebola Under Expanded Access Protocols
September 22, 2014 9:21 AM EDTTekmira Pharmaceuticals (NASDAQ: TKMR) announced that the FDA has authorized Tekmira to provide TKM-Ebola for treatment under expanded access protocols to subjects with confirmed or suspected Ebola virus infections.
"Tekmira is reporting that an appropriate regulatory and clinical framework is now in place to allow the use of TKM-Ebola in patients. We have worked with the FDA and Health Canada to establish this framework and a treatment protocol allowing us to do what we can... More
